{
  "doc_id": "tpn_administration__c684cb",
  "original_filename": "TPN Administration.pdf",
  "md_path": "data/parsed/TPN Administration/TPN Administration.md",
  "rmd_path": "data/parsed/TPN Administration/TPN Administration.rmd",
  "blocks": [
    {
      "type": "table",
      "section": "",
      "line": 0,
      "preview": "|  Stanford MEDICINE | Last Approval Date: February 2024  |"
    },
    {
      "type": "table",
      "section": "",
      "line": 1,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "",
      "line": 2,
      "preview": "|  Procedure Title: Parenteral Nutrition \u2013 TPN, PPN, Lipid Emulsion Intravenous Infusion | Page 1 of"
    },
    {
      "type": "table",
      "section": "",
      "line": 3,
      "preview": "|  Departments Affected: Inpatient Nursing, Emergency Department, Interventional Platform |   |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "I. PURPOSE:",
      "line": 5
    },
    {
      "type": "text",
      "section": "I. PURPOSE:",
      "line": 7,
      "preview": "The purpose of this procedure is to ensure the safe administration of 1) parenteral nutrition and 2)"
    },
    {
      "type": "text",
      "section": "I. PURPOSE:",
      "line": 9,
      "preview": "**Who May Perform:** Registered Nurse (RN)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "II. DEFINITIONS",
      "line": 11
    },
    {
      "type": "heading",
      "level": 3,
      "section": "A. Parenteral nutrition (PN):",
      "line": 13
    },
    {
      "type": "text",
      "section": "A. Parenteral nutrition (PN):",
      "line": 15,
      "preview": "1. Consists of a dextrose and amino acid preparation which is prescribed to meet nutritional require"
    },
    {
      "type": "text",
      "section": "A. Parenteral nutrition (PN):",
      "line": 16,
      "preview": "2. Administered as:"
    },
    {
      "type": "text",
      "section": "A. Parenteral nutrition (PN):",
      "line": 17,
      "preview": "3. a. Total Parenteral Nutrition (TPN) through a central venous access device (CVAD)"
    },
    {
      "type": "text",
      "section": "A. Parenteral nutrition (PN):",
      "line": 18,
      "preview": "4. b. Peripheral Parenteral Nutrition (PPN) through a peripheral catheter."
    },
    {
      "type": "text",
      "section": "A. Parenteral nutrition (PN):",
      "line": 19,
      "preview": "5. Cyclic TPN is the administration of TPN solution over less than 24 hours a day."
    },
    {
      "type": "heading",
      "level": 3,
      "section": "B. Lipid (fat) emulsion:",
      "line": 21
    },
    {
      "type": "text",
      "section": "B. Lipid (fat) emulsion:",
      "line": 23,
      "preview": "Is a component of PN used to prevent essential fatty acid deficiency and provide an additional sourc"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "C. Licensed Independent Practitioner (LIP):",
      "line": 25
    },
    {
      "type": "text",
      "section": "C. Licensed Independent Practitioner (LIP):",
      "line": 27,
      "preview": "Any practitioner permitted by law and the organization to provide care and services, without directi"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "D. Advanced Practice Providers (APP):",
      "line": 29
    },
    {
      "type": "text",
      "section": "D. Advanced Practice Providers (APP):",
      "line": 31,
      "preview": "Include but not limited to physician assistants (PAs), nurse practitioners (NPs), certified register"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "III. SUPPORTIVE INFORMATION:",
      "line": 33
    },
    {
      "type": "heading",
      "level": 3,
      "section": "A. Indications/Contraindications",
      "line": 35
    },
    {
      "type": "text",
      "section": "A. Indications/Contraindications",
      "line": 37,
      "preview": "1. **Indications**"
    },
    {
      "type": "text",
      "section": "A. Indications/Contraindications",
      "line": 38,
      "preview": "2. a. Patients who are malnourished or at risk of malnutrition when enteral feeding is contraindicat"
    },
    {
      "type": "heading",
      "level": 3,
      "section": "B. Precautions",
      "line": 40
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 42,
      "preview": "1. **Reduce infection risk**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 43,
      "preview": "2. a. Verify order to use central line is present before the catheter is used for TPN."
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 44,
      "preview": "3. b. It is preferred to dedicate a single lumen to PN administration when a multi lumen CVAD in pla"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 45,
      "preview": "4. i. For bone marrow transplant (BMT) patients, refer to Appendix B."
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 47,
      "preview": "--- page 1 ---"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 49,
      "preview": "|  Stanford | |"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 50,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 51,
      "preview": "|  MEDICINE | |"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 53,
      "preview": "**Last Approval Date:** February 2024"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 55,
      "preview": "**Procedure Title:** Parenteral Nutrition \u2013 TPN, PPN, Lipid Emulsion"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 57,
      "preview": "**Intravenous Infusion**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 59,
      "preview": "**Departments Affected:** Inpatient Nursing, Emergency Department, Interventional Platform"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 61,
      "preview": "**Page 2 of 8**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 63,
      "preview": "c. Schedule bag, tubing, filter, and dressing changes at the same time whenever possible to minimize"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 65,
      "preview": "d. Change tubing, filter, and solution every 24 hours:"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 67,
      "preview": "i. TPN/PPN"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 69,
      "preview": "ii. Lipids"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 71,
      "preview": "iii. Replace with a new bag even if not completely infused. Refer to Labeling Standardization - Proc"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 73,
      "preview": "1. **Lipid administration**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 75,
      "preview": "a. Do not give lipids to patients with egg, soy, peanut, or fish allergies without a discussion betw"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 77,
      "preview": "b. Lipid emulsion is isotonic and can be given safely through a peripheral line or CVAD"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 79,
      "preview": "1. Monitor labs for tolerance, glucose levels, and metabolic and nutritional status"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 81,
      "preview": "a. Serum glucose levels should be checked at a minimum once daily on all patients receiving TPN."
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 83,
      "preview": "b. If there is any interruption in the administration of the TPN or PPN solution, notify APP/LIP imm"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 85,
      "preview": "1. **Extravasation risk**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 87,
      "preview": "a. PPN may increase risk of phlebitis."
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 89,
      "preview": "b. May administer PPN via peripheral IV if PPN solutions/emulsions have a final concentration of 10%"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 91,
      "preview": "c. Do not use midline catheters for TPN or PPN administration."
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 93,
      "preview": "d. In the event of extravasation, refer to: Extravasation - Early Identification and Management of i"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 95,
      "preview": "IV. **EQUIPMENT/SUPPLIES**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 97,
      "preview": "A. **Infusion pump**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 99,
      "preview": "B. Hospital approved disinfecting port protectors"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 101,
      "preview": "C. Hospital approved disinfecting swab"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 103,
      "preview": "D. **TPN/PPN**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 105,
      "preview": "1. Di[2-ethylhexyl] phthalate (DEHP) free IV Tubing with 1.2 micron filter (add on extension or in-l"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 107,
      "preview": "2. TPN or PPN solution, prepared by pharmacy"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 109,
      "preview": "E. **Lipid**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 111,
      "preview": "1. DEHP free tubing with 1.2 micron filter (add on extension or in-line)"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 113,
      "preview": "2. If infusing with TPN, Luer-Lock Y connector or stopcock"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 115,
      "preview": "3. **Lipid emulsion**"
    },
    {
      "type": "text",
      "section": "B. Precautions",
      "line": 117,
      "preview": "--- page 2 ---"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 119,
      "preview": "|  Stanford MEDICINE | Last Approval Date: February 2024  |"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 120,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 121,
      "preview": "|  Procedure Title: Parenteral Nutrition \u2013 TPN, PPN, Lipid Emulsion Intravenous Infusion |   |"
    },
    {
      "type": "table",
      "section": "B. Precautions",
      "line": 122,
      "preview": "|  Departments Affected: Inpatient Nursing, Emergency Department, Interventional Platform | Page 3 o"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "V. PATIENT AND FAMILY TEACHING",
      "line": 124
    },
    {
      "type": "text",
      "section": "V. PATIENT AND FAMILY TEACHING",
      "line": 126,
      "preview": "- A. Explain procedure to patient and/or family, including the purpose of the parenteral nutrition a"
    },
    {
      "type": "text",
      "section": "V. PATIENT AND FAMILY TEACHING",
      "line": 127,
      "preview": "- B. Instruct patient to inform nursing staff of pain, swelling, or redness at IV insertion site, if"
    },
    {
      "type": "text",
      "section": "V. PATIENT AND FAMILY TEACHING",
      "line": 128,
      "preview": "- C. Explain to patient the signs and symptoms of hypoglycemia if insulin is added to TPN."
    },
    {
      "type": "text",
      "section": "V. PATIENT AND FAMILY TEACHING",
      "line": 129,
      "preview": "- D. Instruct patient about daily care of the central line, if TPN administered."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "VI. PROCEDURE:",
      "line": 131
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 133,
      "preview": "- A. Perform hand hygiene. Don clean gloves."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 134,
      "preview": "- B. Confirm correct formulation aligned with order. Check for:"
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 135,
      "preview": "- Patient's name and medical record number on label."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 136,
      "preview": "- Match all components listed on the label against the Medication Administration Record (MAR)"
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 137,
      "preview": "- C. Verify patient's identification using two patient identifiers (e.g., patient name, date of birt"
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 138,
      "preview": "- D. Inspect the bag before hanging and periodically during administration."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 139,
      "preview": "- Confirm no bag defects or leaks present."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 140,
      "preview": "- Confirm no visible particles or precipitates present."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 141,
      "preview": "- E. Assemble and prime tubing with 1.2-micron filter on distal end of tubing."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 142,
      "preview": "- See Appendix A for tubing diagram."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 143,
      "preview": "- Do not invert filter while priming."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 144,
      "preview": "- F. Set up infusion pump settings using appropriate selections in drug library."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 145,
      "preview": "- Set rate of infusion as ordered."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 146,
      "preview": "- G. Connect tubing(s) to patient and initiate PN infusion."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 147,
      "preview": "- Trace tubing to vascular access device (catheter) before making connections to avoid tubing miscon"
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 148,
      "preview": "- H. Observe patient after starting PN for the following side effects."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 149,
      "preview": "- Side effects may include dyspnea, rash, fever, nausea, dizziness, headache, flushing."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 150,
      "preview": "- Notify LIP/APP if side effects occur."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 151,
      "preview": "- Assess patient every shift for signs and symptoms of glucose, fluid, or electrolyte imbalance."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 152,
      "preview": "- Notify LIP/APP for dextrose containing solution order if PN infusion is interrupted."
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 153,
      "preview": "- Observe the patient for signs and symptoms of hypoglycemia during discontinuation of TPN and notif"
    },
    {
      "type": "text",
      "section": "VI. PROCEDURE:",
      "line": 154,
      "preview": "- Discard PN and lipid emulsion tubings when completed in appropriate waste container."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "VII. EVALUATION",
      "line": 156
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 158,
      "preview": "- A. Monitor flow rate, vital signs, and IV site, as appropriate."
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 160,
      "preview": "--- page 3 ---"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 162,
      "preview": "|  Stanford | |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 163,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 164,
      "preview": "|  MEDICINE | |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 165,
      "preview": "|  Procedure Title: Parenteral Nutrition \u2013 TPN, PPN, Lipid Emulsion | |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 166,
      "preview": "|  Intravenous Infusion | |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 167,
      "preview": "|  Departments Affected: Inpatient Nursing, Emergency Department, | |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 168,
      "preview": "|  Interventional Platform | |"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 170,
      "preview": "B. Evaluate patient tolerance. C. Monitor patient's blood glucose based on clinical condition and in"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 172,
      "preview": "VIII. DOCUMENTATION A. Administration of TPN, PPN and/or lipids B. Document intake volumes per stand"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 174,
      "preview": "IX. COMPLIANCE A. All workforce members including employees, contracted staff, students, volunteers,"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 176,
      "preview": "X. REFERENCES A. Ayers P, Adams S, Boullata J et al. A.S.P.E.N. Parenteral Nutrition Safety Consensu"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 178,
      "preview": "--- page 4 ---"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 180,
      "preview": "|  Stanford | Last Approval Date: February 2024  |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 181,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 182,
      "preview": "|  MEDICINE |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 183,
      "preview": "|  Procedure Title: Parenteral Nutrition \u2013 TPN, PPN, Lipid Emulsion |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 184,
      "preview": "|  Intravenous Infusion |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 185,
      "preview": "|  Departments Affected: Inpatient Nursing, Emergency Department, |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 186,
      "preview": "|  Interventional Platform |   |"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 188,
      "preview": "F. Worthington, P., Balint, J., Bechtold, M., Bingham, A., Chan, L.-N., Durfee, S., Jevenn, A. K., M"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 190,
      "preview": "G. Worthington, P., Gura, K. M., Kraft, M. D., Nishikawa, R., Guenter, P., & Sacks, G. S. (2020). Up"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 192,
      "preview": "XI. RELATED DOCUMENTS / PROCEDURES: A. Total Parenteral Nutrition (TPN) Guidelines B. Refeeding Synd"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 194,
      "preview": "XII. APPENDICES A. Appendix A -Tubing Diagram B. Appendix B- Considerations for BMT Population"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 196,
      "preview": "XIII. DOCUMENT INFORMATION: A. Legal References / Regulatory Requirements: 1. Joint Commission Stand"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 198,
      "preview": "--- page 5 ---"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 200,
      "preview": "|  Stanford | Last Approval Date: February 2024  |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 201,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 202,
      "preview": "|  MEDICINE |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 203,
      "preview": "|  Procedure Title: Parenteral Nutrition - TPN, PPN, Lipid Emulsion |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 204,
      "preview": "|  Intravenous Infusion |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 205,
      "preview": "|  Departments Affected: Inpatient Nursing, Emergency Department, |   |"
    },
    {
      "type": "table",
      "section": "VII. EVALUATION",
      "line": 206,
      "preview": "|  Interventional Platform |   |"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 208,
      "preview": "1. 09/2023 Danielle Smith, RN, NPDS, Professional Practice; Christine Henley, MS, RN, NPDS, Professi"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 209,
      "preview": "2. 01/2024 Patient Care Services, Policy \\& Procedure Committee E. Approvals:"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 210,
      "preview": "3. 11/2023 Nutrition Committee"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 211,
      "preview": "4. 01/2024 Medication Safety Committee"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 212,
      "preview": "5. 01/2024 Pharmacy and Therapeutics"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 213,
      "preview": "6. 02/2024 Practice and Education Council; Patricia Britt DNP, RN, CNS, NEA-BC, Associate Chief Nurs"
    },
    {
      "type": "text",
      "section": "VII. EVALUATION",
      "line": 215,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Appendix A: Tubing Diagram",
      "line": 217
    },
    {
      "type": "heading",
      "level": 2,
      "section": "1PN/PPN/Lipids Tubing Set-Up",
      "line": 219
    },
    {
      "type": "image",
      "section": "1PN/PPN/Lipids Tubing Set-Up",
      "line": 221,
      "content": "![img-0.jpeg](images/5ea93896e6fc4b5b.png)"
    },
    {
      "type": "text",
      "section": "1PN/PPN/Lipids Tubing Set-Up",
      "line": 223,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Appendix B: Considerations for BMT population",
      "line": 225
    },
    {
      "type": "text",
      "section": "Appendix B: Considerations for BMT population",
      "line": 227,
      "preview": "Back to Appendices"
    },
    {
      "type": "text",
      "section": "Appendix B: Considerations for BMT population",
      "line": 229,
      "preview": "1. Do not use a TPN or PPN line for any other purpose, including blood drawing, medication administr"
    },
    {
      "type": "text",
      "section": "Appendix B: Considerations for BMT population",
      "line": 230,
      "preview": "a. Exceptions to the above include blood and marrow transplant recipients (BMT)."
    },
    {
      "type": "text",
      "section": "Appendix B: Considerations for BMT population",
      "line": 231,
      "preview": "2. BMT patients with limited access may have compatible medications infused through the TPN line if "
    },
    {
      "type": "text",
      "section": "Appendix B: Considerations for BMT population",
      "line": 232,
      "preview": "a. These drugs are infused by attaching a multi-access connector (e.g., three-four way stopcocks/man"
    }
  ],
  "images": [
    {
      "sha_name": "5ea93896e6fc4b5b.png",
      "original_ref": "img-0.jpeg",
      "page": 6,
      "relative_path": "images/5ea93896e6fc4b5b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/TPN Administration/images/5ea93896e6fc4b5b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "5ea93896e6fc4b5b"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696506",
    "ts": "2025-08-08T23:41:46.087245+00:00"
  }
}